We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Philip Morris
PM
$299B
| $213M | 0.36% |
2,508,926
+39,590
| +2% | +$3.26M |
|
52
RTX Corp
RTX
$289B
| $211M | 0.35% |
2,240,682
+24,518
| +1% | +$2.22M |
|
53
American Tower
AMT
$81.3B
| $207M | 0.35% |
900,851
+33,755
| +4% | +$7.35M |
|
54
Oracle
ORCL
$367B
| $205M | 0.34% |
3,873,639
-200,923
| -5% | -$11.1M |
|
55
AbbVie
ABBV
$455B
| $205M | 0.34% |
2,314,698
-29,539
| -1% | -$2.45M |
|
56
Thermo Fisher Scientific
TMO
$214B
| $205M | 0.34% |
629,920
-1,202
| -0.2% | -$364K |
|
57
3M
MMM
$90.8B
| $199M | 0.33% |
1,352,003
+23,639
| +2% | +$3.31M |
|
58
Eli Lilly
LLY
$1.03T
| $193M | 0.32% |
1,467,052
-17,652
| -1% | -$2.05M |
|
59
Starbucks
SBUX
$121B
| $193M | 0.32% |
2,190,226
-51,793
| -2% | -$4.42M |
|
60
Linde
LIN
$235B
| $184M | 0.31% |
865,489
+1,657
| +0.2% | +$334K |
|
61
Qualcomm
QCOM
$160B
| $182M | 0.3% |
2,063,490
-127,034
| -6% | -$10.6M |
|
62
CVS Health
CVS
$134B
| $180M | 0.3% |
2,416,978
+50,586
| +2% | +$3.55M |
|
63
Danaher
DHR
$138B
| $171M | 0.29% |
1,255,014
-6,931
| -0.5% | -$876K |
|
64
Lowe's Companies
LOW
$118B
| $166M | 0.28% |
1,388,966
-16,243
| -1% | -$1.86M |
|
65
US Bancorp
USB
$98B
| $165M | 0.28% |
2,789,989
+3,470
| +0.1% | +$201K |
|
66
Elevance Health
ELV
$81.6B
| $160M | 0.27% |
530,621
-33,120
| -6% | -$9.11M |
|
67
Lockheed Martin
LMT
$132B
| $160M | 0.27% |
410,039
-5,544
| -1% | -$2.13M |
|
68
American Express
AXP
$228B
| $157M | 0.26% |
1,258,439
-16,006
| -1% | -$1.91M |
|
69
Booking.com
BKNG
$150B
| $155M | 0.26% |
1,891,375
-26,050
| -1% | -$2.05M |
|
70
Altria Group
MO
$113B
| $154M | 0.26% |
3,075,548
+12,470
| +0.4% | +$588K |
|
71
Fidelity National Information Services
FIS
$23.8B
| $152M | 0.25% |
1,090,249
+10,221
| +0.9% | +$1.37M |
|
72
TJX Companies
TJX
$176B
| $148M | 0.25% |
2,430,387
+6,575
| +0.3% | +$389K |
|
73
Cigna
CI
$76.1B
| $145M | 0.24% |
710,987
-1,639
| -0.2% | -$301K |
|
74
Mondelez International
MDLZ
$80.5B
| $145M | 0.24% |
2,630,191
+32,619
| +1% | +$1.74M |
|
75
GE Aerospace
GE
$368B
| $145M | 0.24% |
2,603,605
+11,983
| +0.5% | +$619K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.